Literature DB >> 22528161

Reverse genetics of influenza viruses.

Gabriele Neumann1, Makoto Ozawa, Yoshihiro Kawaoka.   

Abstract

The ability to modify influenza viruses at will has revolutionized influenza research. Reverse genetics has been used to generate mutant or reassortant influenza viruses to assess their replication, virulence, pathogenicity, host range, and transmissibility. Moreover, this technology is now being used to generate approved influenza virus vaccines and develop novel vaccines to combat seasonal and (future) pandemic influenza viruses. Several variations of the original system have been established, all of which are considerably robust and efficient.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22528161     DOI: 10.1007/978-1-61779-621-0_12

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  9 in total

1.  Influenza A Virus M2 Protein Apical Targeting Is Required for Efficient Virus Replication.

Authors:  Nicholas Wohlgemuth; Andrew P Lane; Andrew Pekosz
Journal:  J Virol       Date:  2018-10-29       Impact factor: 5.103

Review 2.  Vaccines against Major Poultry Viral Diseases: Strategies to Improve the Breadth and Protective Efficacy.

Authors:  Rajamanonmani Ravikumar; Janlin Chan; Mookkan Prabakaran
Journal:  Viruses       Date:  2022-05-31       Impact factor: 5.818

3.  The M2 protein of live, attenuated influenza vaccine encodes a mutation that reduces replication in human nasal epithelial cells.

Authors:  Nicholas Wohlgemuth; Yang Ye; Katherine J Fenstermacher; Hsuan Liu; Andrew P Lane; Andrew Pekosz
Journal:  Vaccine       Date:  2017-10-25       Impact factor: 3.641

Review 4.  A Role for Neutrophils in Viral Respiratory Disease.

Authors:  Jeremy V Camp; Colleen B Jonsson
Journal:  Front Immunol       Date:  2017-05-12       Impact factor: 7.561

5.  Glycosylation of Hemagglutinin and Neuraminidase of Influenza A Virus as Signature for Ecological Spillover and Adaptation among Influenza Reservoirs.

Authors:  Paul Kim; Yo Han Jang; Soon Bin Kwon; Chung Min Lee; Gyoonhee Han; Baik Lin Seong
Journal:  Viruses       Date:  2018-04-07       Impact factor: 5.048

6.  Development of a rapid, simple and efficient one-pot cloning method for a reverse genetics system of broad subtypes of influenza A virus.

Authors:  Won-Suk Choi; Ju Hwan Jeong; Khristine Kaith S Lloren; Su Jeong Ahn; Khristine Joy C Antigua; Young-Il Kim; Young-Jae Si; Yun Hee Baek; Young Ki Choi; Min-Suk Song
Journal:  Sci Rep       Date:  2019-06-05       Impact factor: 4.379

Review 7.  Development and application of reverse genetic technology for the influenza virus.

Authors:  Ziquan Li; Liping Zhong; Jian He; Yong Huang; Yongxiang Zhao
Journal:  Virus Genes       Date:  2021-02-02       Impact factor: 2.332

8.  Efficacy of single dose of a bivalent vaccine containing inactivated Newcastle disease virus and reassortant highly pathogenic avian influenza H5N1 virus against lethal HPAI and NDV infection in chickens.

Authors:  Dong-Hun Lee; Jae-Keun Park; Jung-Hoon Kwon; Seong-Su Yuk; Tseren-Ochir Erdene-Ochir; Yo-Han Jang; Baik-Lin Seong; Joong-Bok Lee; Seung-Yong Park; In-Soo Choi; Chang-Seon Song
Journal:  PLoS One       Date:  2013-03-01       Impact factor: 3.240

9.  H9N2 avian influenza virus in Korea: evolution and vaccination.

Authors:  Dong-Hun Lee; Chang-Seon Song
Journal:  Clin Exp Vaccine Res       Date:  2013-01-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.